Invitrogen Advances 8 Percent on Index
Shares of Invitrogen closed up at $58.49 at market close on Tuesday, 9 percent over last week’s close, to lead gainers over the week on BioCommerce Week’s Index to the Diversified Biology Tools Companies. Overall, the index finished up for a third-straight week at $32.19 from $31.71 one week ago (see table).
The index is a weekly compliation of stock prices of molecular tools companies with multiple platform technologies or business units, executives dedicated to integrated biology efforts, or have made investments in the field. These companies may be the first to react to the demands of the emerging market developing to create a layer of interoperative technology that bridges the data silos of the ‘omics’ industries and provides a broader view of molecular biology processes.
Invitrogen’s rise comes after the company was added to the S&P MidCap 400 Index after the close of trading Monday. PerkinElmer led losers with a 3.6 percent fall, finishing at $18.30 from $18.71 last week.